Analyst Ratings for United Therapeutics Corp. (UTHR)
UTHR Rating Summary
UTHR Price Target Summary
- Highest: $714.00 (Jefferies)
- Lowest: $515.00 (Morgan Stanley)
- Average: $648.62
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$648.62 (+33%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 62%
Rating Score: 5.9 / 10
Percentile Rank: 62%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/20/2026 | JPMorgan » Updated 7/23/2026 |
Jessica Fye | New Coverage | Overweight (N/A) |
687.00 (685.00) |
566.99 (487.61) |
-14% | Details |
| 5/7/2026 | Wells Fargo » Updated 8/6/2026 |
Ben Burnett | Upgrade | Overweight (Equal Weight) |
700.00 (738.00) |
596.76 (487.61) |
-18.29% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
